You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Themis Medicare gains as board to discuss biz operations

Capital Market 

rose 1.01% to Rs 593.70 at 14:22 on after the company said its board will meet on 28 March 2017 to discuss business operations of the company.

The announcement was made during trading hours today, 21 March 2017.

Meanwhile, the S&P Sensex was down 83.70 points, or 0.28% to 29,435.04.

On the BSE, 7,127 shares were traded in the counter so far, compared with average daily volumes of 1,866 shares in the past one quarter. The stock had hit a high of Rs 598 and a low of Rs 583.20 so far during the day. The stock hit a record high of Rs 708.95 on 28 October 2016. The stock hit a 52-week low of Rs 325 on 29 March 2016.

The stock had underperformed the market over the past one month till 20 March 2017, rising 1.16% compared with 3.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 1.33% as against Sensex's 12.20% rise.

The small-cap company has equity capital of Rs 9.04 crore. Face value per share is Rs 10.

On a consolidated basis, Themis Medicare's net profit fell 25.37% to Rs 3.56 crore on 12.48% increase in net sales to Rs 62.11 crore in Q3 December 2016 over Q3 December 2015.

is a pharmaceutical company, engaged in manufacturing pharmaceuticals and medicinal chemicals.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Themis Medicare gains as board to discuss biz operations

Themis Medicare rose 1.01% to Rs 593.70 at 14:22 IST on BSE after the company said its board will meet on 28 March 2017 to discuss business operations of the company.

rose 1.01% to Rs 593.70 at 14:22 on after the company said its board will meet on 28 March 2017 to discuss business operations of the company.

The announcement was made during trading hours today, 21 March 2017.

Meanwhile, the S&P Sensex was down 83.70 points, or 0.28% to 29,435.04.

On the BSE, 7,127 shares were traded in the counter so far, compared with average daily volumes of 1,866 shares in the past one quarter. The stock had hit a high of Rs 598 and a low of Rs 583.20 so far during the day. The stock hit a record high of Rs 708.95 on 28 October 2016. The stock hit a 52-week low of Rs 325 on 29 March 2016.

The stock had underperformed the market over the past one month till 20 March 2017, rising 1.16% compared with 3.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 1.33% as against Sensex's 12.20% rise.

The small-cap company has equity capital of Rs 9.04 crore. Face value per share is Rs 10.

On a consolidated basis, Themis Medicare's net profit fell 25.37% to Rs 3.56 crore on 12.48% increase in net sales to Rs 62.11 crore in Q3 December 2016 over Q3 December 2015.

is a pharmaceutical company, engaged in manufacturing pharmaceuticals and medicinal chemicals.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Themis Medicare gains as board to discuss biz operations

rose 1.01% to Rs 593.70 at 14:22 on after the company said its board will meet on 28 March 2017 to discuss business operations of the company.

The announcement was made during trading hours today, 21 March 2017.

Meanwhile, the S&P Sensex was down 83.70 points, or 0.28% to 29,435.04.

On the BSE, 7,127 shares were traded in the counter so far, compared with average daily volumes of 1,866 shares in the past one quarter. The stock had hit a high of Rs 598 and a low of Rs 583.20 so far during the day. The stock hit a record high of Rs 708.95 on 28 October 2016. The stock hit a 52-week low of Rs 325 on 29 March 2016.

The stock had underperformed the market over the past one month till 20 March 2017, rising 1.16% compared with 3.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 1.33% as against Sensex's 12.20% rise.

The small-cap company has equity capital of Rs 9.04 crore. Face value per share is Rs 10.

On a consolidated basis, Themis Medicare's net profit fell 25.37% to Rs 3.56 crore on 12.48% increase in net sales to Rs 62.11 crore in Q3 December 2016 over Q3 December 2015.

is a pharmaceutical company, engaged in manufacturing pharmaceuticals and medicinal chemicals.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22